Nisonic is developing an advanced ultrasound technology to measure the pressure in the brain (intracranial pressure) in a harmless and cost-effective way. Several indications can affect the intracranial pressure, including head trauma, stroke, meningitis and other central nervous system infections, brain tumours, etc. Today the only accurate measurement method is by invasive insertion of a sensor directly into the cranium, with the risks of bleeding, infections and damage to the brain tissue.
Nisonic’s technology is based on collaboration between researchers at SINTEF and neurosurgeons at the Red Cross War Memorial Children’s Hospital in Cape Town, one of Africa’s largest children’s hospitals, which sees a high number of patients with raised brain pressure. Nisonic is leveraging leading expertise in ultrasound and machine learning for image analysis.
Nisonic AS is a Trondheim, Norway, based medtech company that develops ultrasound technology focusing on neurological conditions. The company has been under management by Cofounder AS since its inception in 2017 and has been supported by Innovation Norway and the Norwegian Research Council.